Strta Skn Scnces (SSKN)


Focuses on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The company's flagship product, MelaFind, features a hand-held imaging device.

    Formally known as:
  • Mela Sciences Inc
Filers who had this stock in their top 10: 0
13F Filers holding this stock: 24
Aggregate shares on 09/30/2015: 2,465,126
Aggregate shares on 06/30/2015: 1,357,070
Percent change: 81.65%
Funds creating new positions: 5
Funds Adding to an existing position: 5
Funds closing out their position: 3
Funds reducing their position: 6
View recent insider trading info

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 09/30/2015

Subscription required

    Stock Split History:
  • 07/10/2014: 1:10

Elevate your investments